
Join to view full profile
130 S Bryn Mawr AveBryn Mawr, PA 19010
Phone+1 484-337-3000
Dr. Toroghi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sam Toroghi is an internal medicine specialist based in Bryn Mawr, PA, with a subspecialty in hospital medicine. He completed his internship and residency in internal medicine at Albert Einstein Healthcare Network from 2016 to 2019, after obtaining his medical degree from Mashhad University of Medical Sciences in 2010. His research includes several published randomized controlled trials, notably on topics such as the prevention of doxorubicin-induced cardiotoxicity and treatments for combat-related chronic posttraumatic stress disorder, which have been cited multiple times in the scientific community.
Education & Training
Jefferson Health Medical Education/Jefferson Einstein Philadelphia HospitalResidency, Internal Medicine, 2017 - 2019
Jefferson Health Medical Education/Jefferson Einstein Philadelphia HospitalInternship, Internal Medicine, 2016 - 2017
Mashhad University of Medical SciencesClass of 2010
Certifications & Licensure
PA State Medical License 2019 - 2034
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 12 citationsEffect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial.Amir Rezaei Ardani, Golkoo Hosseini, Mohammad Reza Fayyazi Bordbar, Ali Talaei, Hesam Mostafavi Toroghi
Journal of Clinical Psychopharmacology. 2017-02-01 - 7 citationsEffects of Dietary Honey andArdehCombination on Chemotherapy- Induced Gastrointestinal and Infectious Complications in Patients with Acute Myeloid Leukemia: A Double-B...Mahmoud Ebrahimi, Abolghasem Allahyari, Hesam H, Golkoo Hosseini, Mohammad Karimi
Iranian Journal of Pharmaceutical Research. 2016-06-01 - 80 citationsCarvedilol Administration Can Prevent Doxorubicin-Induced Cardiotoxicity: A Double-Blind Randomized Trial.Tashakori Beheshti A, Mostafavi Toroghi H, Golkoo Hosseini, Ahmadreza Zarifian, Homaei Shandiz F
Cardiology. 2016-02-12
Journal Articles
- Carvedilol administration can prevent doxorubicin-induced cardio-toxicity: a double-blinded randomized trial.Tashakori Beheshti A, Mostafavi Toroghi H, Hosseini G, Zarifian A, Homaee Shandiz F, Fazlinejad A., Cardiology
- Factors Indicating the Best Reperfusion Method in Acute Myocardial Infarction: Q Wave Better than Time of Onset.Mostafavi Toroghi H, Naghib E, Hosseini G, Mouhebati M, Heidari Bakavoli A., Kuwait Medical Journal, 9/2014
Press Mentions
Wait Times for Emergency Hospitalization RisingSeptember 6th, 2025
Wait Times for Emergency Hospitalization Keep Getting HigherAugust 4th, 2025
Know Your Respiratory Virus Enemies This Season!January 16th, 2025
Professional Memberships
- Member
Other Languages
- Farsi, Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: